<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Relief of right ventricular (RV) outflow tract obstruction in <z:hpo ids='HP_0001636'>tetralogy of Fallot</z:hpo> or similar <z:mp ids='MP_0001532'>physiology</z:mp> often results in <z:mp ids='MP_0006048'>pulmonary regurgitation</z:mp> (PR) </plain></SENT>
<SENT sid="1" pm="."><plain>The resultant <z:hpo ids='HP_0011010'>chronic</z:hpo> volume overload can lead to RV <z:mpath ids='MPATH_66'>dilatation</z:mpath>, biventricular dysfunction, <z:hpo ids='HP_0001635'>heart failure</z:hpo> symptoms, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and <z:hpo ids='HP_0001699'>sudden death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Although pulmonary valve replacement (PVR) can lead to improvement in the functional class and a substantial decrease or normalization of RV volumes, the optimal timing of PVR is not well defined </plain></SENT>
<SENT sid="3" pm="."><plain>Benefits of PVR have to be weighed against the risks of this procedure including subsequent reoperation </plain></SENT>
<SENT sid="4" pm="."><plain>This article reviews the pathophysiology of <z:hpo ids='HP_0011010'>chronic</z:hpo> PR, evidence-based benefits and risks of PVR, options for valve substitute, and optimal timing of PVR in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> PR after relief of RV outflow tract obstruction </plain></SENT>
</text></document>